Eversept Partners, LP Igm Biosciences, Inc. Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$51.3 - $75.21 $501,201 - $734,801	-9,770 Closed	0 $0
Q1 2020 Nov 08, 2023	SELL	$31.51 - $73.75 $1.73 Million - $4.04 Million	-54,830 Reduced 84.88%	9,770 $548,000
Q1 2020 May 13, 2020	SELL	$31.51 - $73.75 $1.73 Million - $4.04 Million	-54,830 Reduced 84.88%	9,770 $549,000
Q4 2019 Nov 08, 2023	BUY	$17.25 - $49.51 $1.11 Million - $3.2 Million	64,600 New	64,600 $2.47 Million
Q4 2019 Feb 13, 2020	BUY	$17.25 - $49.51 $1.11 Million - $3.2 Million	64,600 New	64,600 $2.47 Million

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.